The monkeypox virus poses a novel public health risk that might quickly escalate into a worldwide epidemic. Machine learning (ML) has recently shown much promise in diagnosing diseases like cancer, finding tumor cells, and finding COVID-19 patients. In this study, we have created a dataset based on the data both collected and published by Global Health, and used by the World Health Organization (WHO). Being entirely textual, this dataset shows the relationship between the symptoms and the monkeypox disease. The data has been analyzed, using gradient boosting methods such as Extreme Gradient Boosting (XGBoost), CatBoost, and LightGBM along with other standard machine learning methods such as Support Vector Machine (SVM) and Random Forest. All these methods have been compared. The research aims at providing an ML model based on symptoms to diagnose monkeypox. Previous studies have only examined disease diagnosis-using images. The best performance has belonged to XGBoost, with an accuracy of 1.0 in reviews. To check the model’s flexibility, k-fold cross-validation is used, reaching an average accuracy of 0.9 in 5 different split of test set. In addition, Shapley Additive Explanations (SHAP) helps examining and explaining the output of the XGBoost model.

Financial time series prediction, a growing research topic, has attracted considerable interest from scholars, and several approaches have been developed. Among them, decomposition-based methods have achieved promising results. Most decomposition-based methods approximate a single function, which is insufficient for obtaining accurate results. Moreover, most existing researches have concentrated on one-step-ahead forecasting that prevents stock market investors from arriving at the best decisions for the future. This study proposes two novel methods for multi-step-ahead stock price prediction based on the issues outlined. DCT-MFRFNN, a method based on discrete cosine transform (DCT) and multi-functional recurrent fuzzy neural network (MFRFNN), uses DCT to reduce fluctuations in the time series and simplify its structure and MFRFNN to predict the stock price. VMD-MFRFNN, an approach based on variational mode decomposition (VMD) and MFRFNN, brings together their advantages. VMD-MFRFNN consists of two phases. The input signal is decomposed to several IMFs using VMD in the decomposition phase. In the prediction and reconstruction phase, each of the IMFs is given to a separate MFRFNN for prediction, and predicted signals are summed to reconstruct the output. Three financial time series, including Hang Seng Index (HSI), Shanghai Stock Exchange (SSE), and Standard & Poor’s 500 Index (SPX), are used for the evaluation of the proposed methods. Experimental results indicate that VMD-MFRFNN surpasses other state-of-the-art methods. VMD-MFRFNN, on average, shows 35.93%, 24.88%, and 34.59% decreases in RMSE from the second-best model for HSI, SSE, and SPX, respectively. Also, DCT-MFRFNN outperforms MFRFNN in all experiments.

The new coronavirus (known as COVID-19) was first identified in Wuhan and quickly spread worldwide, wreaking havoc on the economy and people’s everyday lives. Fever, cough, sore throat, headache, exhaustion, muscular aches, and difficulty breathing are all typical symptoms of COVID-19. A reliable detection technique is needed to identify affected individuals and care for them in the early stages of COVID-19 and reduce the virus’s transmission. The most accessible method for COVID-19 identification is RT-PCR; however, due to its time commitment and false-negative results, alternative options must be sought. Indeed, compared to RT-PCR, chest CT scans and chest X-ray images provide superior results. Because of the scarcity and high cost of CT scan equipment, X-ray images are preferable for screening. In this paper, a pre-trained network, DenseNet169, was employed to extract features from X-ray images. Features were chosen by a feature selection method (ANOVA) to reduce computations and time complexity while overcoming the curse of dimensionality to improve predictive accuracy. Finally, selected features were classified by XGBoost. The ChestX-ray8 dataset, which was employed to train and evaluate the proposed method. This method reached 98.72% accuracy for two-class classification (COVID-19, healthy) and 92% accuracy for three-class classification (COVID-19, healthy, pneumonia).